0

Journal Articles

in Hypertension
 121-140 of 177 Articles
Editorial |  May 21, 2003
JNC 7—It's More Than High Blood Pressure
Thomas E. Kottke, MD, MSPH; Robert J. Stroebel, MD; Rebecca S. Hoffman, BA
JAMA. 2003;289(19):2573-2575. doi:10.1001/jama.289.19.2573.
Review |  May 21, 2003 FREE
Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents:  A Network Meta-analysis
Bruce M. Psaty, MD, PhD; Thomas Lumley, PhD; Curt D. Furberg, MD, PhD; et al.
JAMA. 2003;289(19):2534-2544. doi:10.1001/jama.289.19.2534.
Special Communication |  May 21, 2003
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure:  The JNC 7 Report
Aram V. Chobanian, MD; George L. Bakris, MD; Henry R. Black, MD; et al.
JAMA. 2003;289(19):2560-2571. doi:10.1001/jama.289.19.2560.
Editorial |  May 14, 2003
Hypertension Prevalence and Stroke Mortality Across Populations
Jan A. Staessen, MD, PhD; Tatiana Kuznetsova, MD; Katarzyna Stolarz, MD
JAMA. 2003;289(18):2420-2422. doi:10.1001/jama.289.18.2420.
Original Contribution |  May 14, 2003 FREE
Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United States
Katharina Wolf-Maier, MD; Richard S. Cooper, MD; José R. Banegas, MD; et al.
JAMA. 2003;289(18):2363-2369. doi:10.1001/jama.289.18.2363.
The World in Medicine |  May 14, 2003
Surge in Global Cancer Rates?
JAMA. 2003;289(18):2349. doi:10.1001/jama.289.18.2349-a.
The World in Medicine |  April 09, 2003
Obesity-Hypertension Link in Children?
JAMA. 2003;289(14):1774. doi:10.1001/jama.289.14.1774-a.
Original Contribution |  March 26, 2003 FREE
Blood Lead, Blood Pressure, and Hypertension in Perimenopausal and Postmenopausal Women
Denis Nash, PhD, MPH; Laurence Magder, PhD, MPH; Mark Lustberg, PhD; et al.
JAMA. 2003;289(12):1523-1532. doi:10.1001/jama.289.12.1523.
Commentary |  February 26, 2003
Measuring Blood Pressure Accurately:  New and Persistent Challenges
Daniel W. Jones, MD; Lawrence J. Appel, MD, MPH; Sheldon G. Sheps, MD; et al.
JAMA. 2003;289(8):1027-1030. doi:10.1001/jama.289.8.1027.
Medical News and Perspectives |  February 05, 2003
Researchers Say Changes Needed in Recruitment Policies for NIH Trials
JAMA. 2003;289(5):536-537. doi:10.1001/jama.289.5.536.
Editorial |  December 18, 2002
The Verdict From ALLHAT—Thiazide Diuretics Are the Preferred Initial Therapy for Hypertension
Lawrence J. Appel, MD, MPH
JAMA. 2002;288(23):3039-3042. doi:10.1001/jama.288.23.3039.
Original Contribution |  December 18, 2002 FREE
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic:  The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
JAMA. 2002;288(23):2981-2997. doi:10.1001/jama.288.23.2981.
Original Contribution |  December 18, 2002 FREE
Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care:  The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
JAMA. 2002;288(23):2998-3007. doi:10.1001/jama.288.23.2998.
Editorial |  November 20, 2002
Hypertension Control and Kidney Disease:  Some Questions Answered, Many Remain
Michael H. Alderman, MD
JAMA. 2002;288(19):2466-2467. doi:10.1001/jama.288.19.2466.
Original Contribution |  November 20, 2002 FREE
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease:  Results From the AASK Trial
Jackson T. Wright, Jr, MD, PhD; George Bakris, MD; Tom Greene, PhD; et al.
JAMA. 2002;288(19):2421-2431. doi:10.1001/jama.288.19.2421.
From the World Health Organization |  October 23, 2002
Reducing Risks to Health, Promoting Healthy Life
JAMA. 2002;288(16):1974. doi:10.1001/jama.288.16.1974.
Special Communication |  October 16, 2002
Primary Prevention of Hypertension:  Clinical and Public Health Advisory From the National High Blood Pressure Education Program
Paul K. Whelton, MD, MSc; Jiang He, MD, PhD; Lawrence J. Appel, MD, MPH; et al.
JAMA. 2002;288(15):1882-1888. doi:10.1001/jama.288.15.1882.
Special Communication |  October 02, 2002
Exercise Training and the Cardiovascular Consequences of Type 2 Diabetes and Hypertension:  Plausible Mechanisms for Improving Cardiovascular Health
Kerry J. Stewart, EdD
JAMA. 2002;288(13):1622-1631. doi:10.1001/jama.288.13.1622.
Original Contribution |  September 25, 2002 FREE
Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy:  A Losartan Intervention For Endpoint Reduction (LIFE) Substudy
Sverre E. Kjeldsen, MD; Björn Dahlöf, MD; Richard B. Devereux, MD; et al.
JAMA. 2002;288(12):1491-1498. doi:10.1001/jama.288.12.1491.
Original Contribution |  May 15, 2002 FREE
Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes
The CDC Diabetes Cost-effectiveness Group
JAMA. 2002;287(19):2542-2551. doi:10.1001/jama.287.19.2542.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Waste and Harm in the Treatment of Mild Hypertension
Iona Heath, MA, MB, BCh
JAMA Internal Medicine
Original Investigation  |  June 10, 2013
Device-Guided Breathing as Treatment for Hypertension in Type 2 Diabetes Mellitus:  A Randomized, Double-blind, Sham-Controlled Trial
Gijs W. D. Landman, MD, PhD; Iefke Drion, MD; Kornelis J. J. van Hateren, MD, PhD; et al.
JAMA Internal Medicine
Editor's Correspondence  |  June 10, 2013
Noncommunicable Diseases in Developing Countries: Focus on Research Capacity Building
Ayodele Odutayo, BHSc; Naheed Hirji, BASc
JAMA Internal Medicine
Editor's Correspondence  |  May 27, 2013
Risk of Hip Fracture and Antihypertensive Drugs in Older People
Shih-Wei Lai, MD; Kuan-Fu Liao, MD, MS
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems